1. Home
  2. SYBX vs MHUA Comparison

SYBX vs MHUA Comparison

Compare SYBX & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • MHUA
  • Stock Information
  • Founded
  • SYBX N/A
  • MHUA 1990
  • Country
  • SYBX United States
  • MHUA China
  • Employees
  • SYBX N/A
  • MHUA N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • SYBX Health Care
  • MHUA Health Care
  • Exchange
  • SYBX Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • SYBX 16.4M
  • MHUA 19.6M
  • IPO Year
  • SYBX N/A
  • MHUA 2022
  • Fundamental
  • Price
  • SYBX $1.46
  • MHUA $0.41
  • Analyst Decision
  • SYBX
  • MHUA
  • Analyst Count
  • SYBX 0
  • MHUA 0
  • Target Price
  • SYBX N/A
  • MHUA N/A
  • AVG Volume (30 Days)
  • SYBX 53.6K
  • MHUA 96.7K
  • Earning Date
  • SYBX 08-07-2025
  • MHUA 09-19-2025
  • Dividend Yield
  • SYBX N/A
  • MHUA N/A
  • EPS Growth
  • SYBX N/A
  • MHUA N/A
  • EPS
  • SYBX N/A
  • MHUA 0.40
  • Revenue
  • SYBX N/A
  • MHUA $96,909,642.00
  • Revenue This Year
  • SYBX N/A
  • MHUA N/A
  • Revenue Next Year
  • SYBX N/A
  • MHUA N/A
  • P/E Ratio
  • SYBX N/A
  • MHUA $1.05
  • Revenue Growth
  • SYBX N/A
  • MHUA N/A
  • 52 Week Low
  • SYBX $0.90
  • MHUA $0.25
  • 52 Week High
  • SYBX $1.96
  • MHUA $1.26
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 52.54
  • MHUA 52.15
  • Support Level
  • SYBX $1.33
  • MHUA $0.39
  • Resistance Level
  • SYBX $1.67
  • MHUA $0.42
  • Average True Range (ATR)
  • SYBX 0.12
  • MHUA 0.03
  • MACD
  • SYBX -0.01
  • MHUA 0.00
  • Stochastic Oscillator
  • SYBX 38.24
  • MHUA 72.00

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: